Adaptive Clinical Trial Design in Head-to-Head Comparison of Two DPP-4 Inhibitors

Time

Wed, Jun 17 9:00AM
W 31

Title

Adaptive Clinical Trial Design in Head-to-Head Comparison of Two DPP-4 Inhibitors

Abstract Summary

ORAL PRESENTATION SCHEDULED: Wednesday, June 17 in Session #2B at 1:13 - 1:18 pm in the Exhibit Hall Poster Area (Hall A entrance)

This was a multicenter open-label randomized clinical trial in Russia. 299 treatment naïve patients with T2DM were enrolled in two treatment groups (1:1) and consecutively entered two study periods: monotherapy and combination therapy. Change of HbA1c was the primary efficacy endpoint.

Poster Presenter

Natalia Vostokova
PharmD,
COO,
IPHARMA LLC
Russian Federation